Claus Braestrup is Proposed as New Chairman of the Board of Directors in Pharmexa
16 mai 2002 05h10 HE
|
Pharmexa A/S
HORSHOLM, Denmark, May 16, 2002 (PRIMEZONE) -- The Board of Directors in Pharmexa propose that Executive Vice President of Research and Development in H. Lundbeck, Claus Braestrup is elected new...
Pharmexa In-Licenses Formulation Technology from ZYCOS for the AutoVac HER-2 DNA Therapeutic Cancer Vaccine
15 mai 2002 08h26 HE
|
Pharmexa A/S
HORSHOLM, Denmark, May 15, 2002 (PRIMEZONE) -- Pharmexa and ZYCOS today jointly announced that they have entered into an agreement to formulate Pharmexa's therapeutic DNA breast cancer vaccine in...
Pharmexa A/S: Inoxell Receives Acceptance of its Scaffold Technology Patent from the European Patent Office
24 avr. 2002 11h16 HE
|
Pharmexa A/S
HORSHOLM, Denmark, April 24, 2002 (PRIMEZONE) -- Pharmexa's 83.3% owned subsidiary Inoxell A/S today announced that the European Patent Office has issued an acceptance of Inoxell's patent on its...
Pharmexa Announces that GlaxoSmithKline has Exclusive Option on HER-2 Protein Breast Cancer Project
12 avr. 2002 05h07 HE
|
Pharmexa A/S
HORSHOLM, Denmark, April 12, 2002 (PRIMEZONE) -- In June 2001 Pharmexa announced that it had in-licensed a vector-cell production system from GlaxoSmithKline (NYSE:GSK) for use in Pharmexa's...
Pharmexa Presents at the 3rd European Breast Cancer Conference in Barcelona
20 mars 2002 11h25 HE
|
Pharmexa A/S
BARCELONA, Spain, March 20, 2002 (PRIMEZONE) -- Dr. Dana Leach, Vice President of Preclinical Development and Immunopharmacology at Pharmexa, today presented the company's HER-2 DNA AutoVac(tm)...
Pharmexa Group: Annual Report 2001 (with link)
15 mars 2002 10h16 HE
|
Pharmexa A/S
HORSHOLM, Denmark, March 15, 2002 (PRIMEZONE) -- Pharmexa Group's Board of Directors, in a meeting today, approved the audited financial statements for the financial year 2001.
The Pharmexa Group...
David Gee Joins Pharmexa as Director of Licensing
14 mars 2002 05h05 HE
|
Pharmexa A/S
HORSHOLM, Denmark, March 14, 2002 (PRIMEZONE) -- Pharmexa today announced the appointment of David Gee as Director of Licensing. David joins Pharmexa to manage the out-licensing activities of the...